Why the study?
Is the ATS 3f Enable Sutureless Bioprosthesis safe and effective for patients undergoing aortic valve replacement?
Population
140 patients undergoing isolated aortic valve replacement with or without concomitant procedures, mean age…
Design
Cohort
Follow-up
121.8 patient-years total accumulated follow-up
Authors
Loading...
Supports midterm hemodynamic performance of sutureless AVR; leaves open durability and comparative efficacy versus conventional valves.
Is the ATS 3f Enable Sutureless Bioprosthesis safe and effective for patients undergoing aortic valve replacement?
The ATS 3f Enable sutureless bioprosthesis demonstrates feasible and safe implantation with excellent hemodynamics and clinical improvement at midterm follow-up.
Martens et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: